In the last trading session, 32.82 million shares of the Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) were traded, and its beta was -0.15. Most recently the company’s share price was $2.08, and it changed around $0.77 or 58.78% from the last close, which brings the market valuation of the company to $4.68M. LIXT currently trades at a discount to its 52-week high of $4.42, offering almost -112.5% off that amount. The share price’s 52-week low was $1.31, which indicates that the current value has risen by an impressive 37.02% since then. We note from Lixte Biotechnology Holdings Inc’s average daily trading volume that its 10-day average is 3.37 million shares, with the 3-month average coming to 63.19K.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) trade information
Instantly LIXT has showed a green trend with a performance of 58.78% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 2.3900 on recent trading dayincreased the stock’s daily price by 12.97%. The company’s shares are currently down -11.49% year-to-date, but still up 4.00% over the last five days. On the other hand, Lixte Biotechnology Holdings Inc (NASDAQ:LIXT) is 11.23% up in the 30-day period. We can see from the shorts that 18324.0 shares have been sold at a short interest cover period of 2.38 day(s).
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -4.05%.
LIXT Dividends
Lixte Biotechnology Holdings Inc’s next quarterly earnings report is expected to be released in November.
Lixte Biotechnology Holdings Inc (NASDAQ:LIXT)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 20.48% of Lixte Biotechnology Holdings Inc shares, and 8.88% of them are in the hands of institutional investors. The stock currently has a share float of 11.17%.
